ROCHE INVIRASE CLEARS FDA IN 97 DAYS AS FIRST APPROVED PROTEASE INHIBITOR: NEW FORMULATION IN STUDY; INTERNATIONAL CONFIMATORY TRIAL SIZE, POWER INCREASED

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".